Only a few days to go: We’re raising £25,000 to keep TheyWorkForYou running and make sure people across the UK can hold their elected representatives to account.

Donate to our crowdfunder

NHS: Drugs and Medicines

House of Lords written question – answered on 13th May 2014.

Alert me about debates like this

Photo of Lord Oakeshott of Seagrove Bay Lord Oakeshott of Seagrove Bay Liberal Democrat

To ask Her Majesty’s Government, for each of the last three years for which figures are available, what was the total National Health Service expenditure on drugs and medicines produced by (1) AstraZeneca, (2) Pfizer, and (3) GlaxoSmithKline; and what percentage of the National Health Service’s total expenditure on drugs and medicines each of those figures represents.

Photo of Earl Howe Earl Howe The Parliamentary Under-Secretary of State for Health

The following table sets out for 2011, 2012 and 2013, National Health Service spend on medicines and percentage of spend, for AstraZeneca, Pfizer and GlaxoSmithKline in primary care only.

This does not include data on NHS use of medicines in hospitals, as comparable current data sources do not take account of the discounts available.

Net ingredient cost and proportion of all primary care spend by manufacturer, in England, for the years 2011, 2012 and 2013, based on prescription items dispensed in the community in England.1
2011 2012 2013
Manufacturer name Net Ingredient Cost (£000s) Percentage of all Primary Care Net Ingredient Cost (£000s) Percentage of all Primary Care Net Ingredient Cost (£000s) Percentage of all Primary Care
AstraZeneca 451,931 5.5 366,037 4.7 353,981 4.5
Pfizer 771,631 9.5 521,610 6.7 408,643 5.2
GlaxoSmithKline 597,634 7.3 565,881 7.2 542,992 6.9
Total (all primary care expenditure on medicines in England2) 8,164,364 100.0 7,840,390 100.0 7,888,304 100.0

Source:

Prescription Cost Analysis provided by the Health and Social Care Information Centre

Notes:

1.

This may not include spend on those medicines made by the companies that are also available generically.

2.

This total relates to all medicines contained within British National Formulary (BNF) Chapters 1 to 19. The cost of dressings and appliances contained within BNF Chapters 20 to 23 has been excluded.

Does this answer the above question?

Yes2 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.